Oncology biotech Immix Biopharma files for a $25 million IPOSeptember 17, 2021Immix Biopharma, a Phase 1b/2a biotech developing tissue-specific therapies for solid tumors, filed on Friday with the SEC to raise up to $25 million in an initial public offering. Immix is developing a novel class […]
Oncodisc To Combine With PAVmed Subsidiary Veris Health To Advance Development Of Next-Generation Intelligent Implantable Remote Care Technology Initially Benefiting 17 Million Annual Global Cancer Patients WALNUT CREEK, Calif., June 2, 2021 /PRNewswire/ — Oncodisc Inc. (“Oncodisc”) today announced that it was acquired by Veris Health […]
Brain tumors are a widespread condition. The number of patients diagnosed with cancer globally will grow from 17 million (2018) to 27.5 million (2040). Of those, it is estimated that at in least 9%, or 1.5 million of those patients, their cancers will spread – metastasize […]
Subscribe – Put Your Email In This Box